Raises FY24 operating revenue view to $5.325B-$5.375B from $5.275B-$5.350. Consensus is for FY24 EPS $4.19 and for revenue $5.32B. Raises FY24 adjusted EBITDA to $1.070B-$1.090B from $1.040B-$1.075B.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC:
- Encompass Health reports Q3 cont. ops. EPS $1.07, consensus 94c
- EHC Upcoming Earnings Report: What to Expect?
- Encompass Health price target raised to $108 from $104 at Truist
- Encompass Health initiated with an Overweight at KeyBanc
- Encompass Health price target raised to $105 from $95 at RBC Capital